Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Alley

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Journal of Cataract and Refractive Surgery|March 12, 2018
Intraocular lens power adjustment by a femtosecond laser: In vitro evaluation of power change, modulation transfer function, light transmission, and light scattering in a blue light-filtering lensJason Nguyen, Liliana Werner, Jason Ludlow, et al.
Journal of Cataract and Refractive Surgery|September 18, 2017
Biocompatibility of intraocular lens power adjustment using a femtosecond laser in a rabbit modelLiliana Werner, Jason Ludlow, Jason Nguyen, et al.
ACS Infectious Diseases|April 2, 2025
Time-Dependent Inhibition of Leucyl-tRNA-Synthetase (LeuRS): Insight into Target VulnerabilityMingqian Wang, YongLe He, Siobhan A Cohen, et al.
Journal of Medicinal Chemistry|July 21, 2006
Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosisStephen J Baker, Yong-Kang Zhang, Tsutomu Akama, et al.
ACS Chemical Biology|December 3, 2025
Selectivity of the Time-Dependent <i>M. tuberculosis</i> LeuRS Inhibitor Ganfeborole Is Driven by Target VulnerabilityMingqian Wang, YongLe He, Siobhan A Cohen, et al.
Antimicrobial Agents and Chemotherapy|July 5, 2017
A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis <i>In Vitro</i>Nipul Patel, Theresa O'Malley, Yong-Kang Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 1991
Apoptosis: a general commentA Alles, K Alley, J C Barrett, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2018
Clinical and veterinary trypanocidal benzoxaboroles target CPSF3Richard J Wall, Eva Rico, Iva Lukac, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosisAaron Korkegian, Theresa O'Malley, Yi Xia, et al.
Journal of Medicinal Chemistry|February 17, 2011
Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agentsDazhong Ding, Qingqing Meng, Guangwei Gao, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Journal of Cataract and Refractive Surgery|March 12, 2018
Intraocular lens power adjustment by a femtosecond laser: In vitro evaluation of power change, modulation transfer function, light transmission, and light scattering in a blue light-filtering lensJason Nguyen, Liliana Werner, Jason Ludlow, et al.
Journal of Cataract and Refractive Surgery|September 18, 2017
Biocompatibility of intraocular lens power adjustment using a femtosecond laser in a rabbit modelLiliana Werner, Jason Ludlow, Jason Nguyen, et al.
ACS Infectious Diseases|April 2, 2025
Time-Dependent Inhibition of Leucyl-tRNA-Synthetase (LeuRS): Insight into Target VulnerabilityMingqian Wang, YongLe He, Siobhan A Cohen, et al.
Journal of Medicinal Chemistry|July 21, 2006
Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1- benzoxaborole (AN2690), for the potential treatment of onychomycosisStephen J Baker, Yong-Kang Zhang, Tsutomu Akama, et al.
ACS Chemical Biology|December 3, 2025
Selectivity of the Time-Dependent <i>M. tuberculosis</i> LeuRS Inhibitor Ganfeborole Is Driven by Target VulnerabilityMingqian Wang, YongLe He, Siobhan A Cohen, et al.
Antimicrobial Agents and Chemotherapy|July 5, 2017
A Novel 6-Benzyl Ether Benzoxaborole Is Active against Mycobacterium tuberculosis <i>In Vitro</i>Nipul Patel, Theresa O'Malley, Yong-Kang Zhang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 1991
Apoptosis: a general commentA Alles, K Alley, J C Barrett, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 7, 2018
Clinical and veterinary trypanocidal benzoxaboroles target CPSF3Richard J Wall, Eva Rico, Iva Lukac, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
The 7-phenyl benzoxaborole series is active against Mycobacterium tuberculosisAaron Korkegian, Theresa O'Malley, Yi Xia, et al.
Journal of Medicinal Chemistry|February 17, 2011
Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agentsDazhong Ding, Qingqing Meng, Guangwei Gao, et al.
Pageof 5